In March 2025, the company announced new programs for a direct-to-consumer presenting of its Wegovy weight loss drug. The company recognized a new pharmacy, termed NovoCare, which might cost shoppers $499 each month for use of the drug, lower than half the cost of the drug as a result of other pharmaceutical distribution networks.[fifty three]In Oc